News
PYPD
3.585
+11.34%
0.365
Weekly Report: what happened at PYPD last week (1216-1220)?
Weekly Report · 7h ago
PolyPid’s Strategic Advancements and Clinical Progress: A Buy Recommendation
TipRanks · 12/16 11:36
Weekly Report: what happened at PYPD last week (1209-1213)?
Weekly Report · 12/16 09:44
PolyPid Ltd. Announces Research Collaboration with ImmunoGenesis to Enhance Immunotherapy for Solid Tumors
Barchart · 12/11 16:18
PolyPid (PYPD) Gets a Buy from Craig-Hallum
TipRanks · 12/11 13:47
PolyPid Collaborates with ImmunoGenesis to Boost Cancer Immunotherapy
TipRanks · 12/11 12:28
PolyPid announces research, development collaboration with ImmunoGenesis
TipRanks · 12/11 12:16
POLYPID ANNOUNCES RESEARCH AND DEVELOPMENT COLLABORATION WITH IMMUNOGENESIS LEVERAGING PLEX TECHNOLOGY TO ENHANCE CANCER IMMUNOTHERAPY
Reuters · 12/11 12:00
Weekly Report: what happened at PYPD last week (1202-1206)?
Weekly Report · 12/09 09:43
PolyPid receives Nasdaq’s non-compliance letter
Seeking Alpha · 12/02 15:23
Weekly Report: what happened at PYPD last week (1125-1129)?
Weekly Report · 12/02 09:43
PolyPid Ltd. Faces Nasdaq Non-Compliance Notification Due to Stockholders' Equity Shortfall
Barchart · 11/29 22:24
PolyPid Faces Nasdaq Non-Compliance Challenge
TipRanks · 11/29 18:28
PolyPid Receives Non-Compliance Letter From Nasdaq
Benzinga · 11/29 18:10
PolyPid receives noncompliance notification from Nasdaq
TipRanks · 11/29 18:10
POLYPID ANNOUNCES RECEIPT OF NASDAQ NOTIFICATION OF MINIMUM STOCKHOLDERS’ EQUITY NON-COMPLIANCE
Reuters · 11/29 18:05
Weekly Report: what happened at PYPD last week (1118-1122)?
Weekly Report · 11/25 09:41
Weekly Report: what happened at PYPD last week (1111-1115)?
Weekly Report · 11/18 09:40
PolyPid (PYPD) Gets a Hold from Barclays
TipRanks · 11/18 09:07
Positive Indicators and Financial Stability Support Roy Buchanan’s Optimistic Outlook on PolyPid’s Stock
TipRanks · 11/14 15:55
More
Webull provides a variety of real-time PYPD stock news. You can receive the latest news about Polypid Ltd. through multiple platforms. This information may help you make smarter investment decisions.
About PYPD
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.